Castleview Partners’s Fate Therapeutics FATE Stock Holding History

Castleview Partners’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$34.5K	Sell
2024 Q3	$72.9K	Buy